<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="H086633F7E8684AE8BE44DF7640DFAA30" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>118 HR 1754 IH: Healthcare Ownership Transparency Act</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2023-03-23</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">118th CONGRESS</congress><session display="yes">1st Session</session><legis-num display="yes">H. R. 1754</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20230323">March 23, 2023</action-date><action-desc><sponsor name-id="J000298">Ms. Jayapal</sponsor> (for herself, <cosponsor name-id="B001223">Mr. Bowman</cosponsor>, <cosponsor name-id="D000399">Mr. Doggett</cosponsor>, <cosponsor name-id="G000586">Mr. García of Illinois</cosponsor>, <cosponsor name-id="G000551">Mr. Grijalva</cosponsor>, <cosponsor name-id="S001205">Ms. Scanlon</cosponsor>, and <cosponsor name-id="S000510">Mr. Smith of Washington</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name>, and in addition to the Committee on <committee-name committee-id="HWM00">Ways and Means</committee-name>, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned</action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To amend title XI of the Social Security Act to provide for the disclosure and analysis of certain health-related ownership information.</official-title></form><legis-body id="H5B7C6493E401412FA800D770A71C29DB" style="OLC"><section id="H7519F47900614AD3943B6F20D315F480" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Healthcare Ownership Transparency Act</short-title></quote>.</text></section><section id="H682FBB0A28154C2B9BC3EC07EF76DDCC"><enum>2.</enum><header>Disclosure and analysis of certain health-related ownership information</header><subsection id="HCBECEE489FE24A0F8480B1038E05E985"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">Part A of title XI of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1301">42 U.S.C. 1301 et seq.</external-xref>) is amended by adding at the end the following new section:</text><quoted-block style="OLC" id="HCB55463799A248578AE1D4ADB3C15E48" display-inline="no-display-inline"><section id="H20E3E8B263694DC8891D9616884FF015"><enum>1150C.</enum><header>Disclosure and analysis of certain health-related ownership information</header><subsection id="H18B00651F6E942BF972AA12A0A9129D5"><enum>(a)</enum><header>Required disclosure of certain health-related private equity ownership information</header><text display-inline="yes-display-inline">The Secretary shall issue rules to require a covered firm to submit to the Secretary, through the Provider Enrollment, Chain, and Ownership System as part of the enrollment and revalidation of enrollment processes under title XVIII for providers of services and suppliers—</text><paragraph id="H5C5A28BFD9374BE78DBBF992E939100F"><enum>(1)</enum><text>for a covered firm with respect to which there is a private equity fund that is a control person of the covered fund, the information described in subsection (b); and</text></paragraph><paragraph id="HFB14F3DD631E4F9DBD62E557B7B2A107"><enum>(2)</enum><text display-inline="yes-display-inline">for a covered firm not described under paragraph (1), the information described in subsection (c).</text></paragraph></subsection><subsection id="H705B84135BD742E096FFD3882ADD519D"><enum>(b)</enum><header>Information submitted by covered firms owned by private equity</header><text display-inline="yes-display-inline">For purposes of subsection (a) and with respect to a covered firm and each private equity fund that is a control person of the covered firm, the information described in this subsection is the following information with respect to each year of the previous 10-year period:</text><paragraph id="H176609426A30420492BC355074548BB1" display-inline="no-display-inline"><enum>(1)</enum><text display-inline="yes-display-inline">The percentage of the equity of the private equity fund contributed by—</text><subparagraph id="H7F57603D8C4B40B0A9529517808A1F62"><enum>(A)</enum><text>the general partners of the fund; and</text></subparagraph><subparagraph id="H4B0C70E9906842BC9CBFCE44C634539D"><enum>(B)</enum><text>the limited partners of the fund.</text></subparagraph></paragraph><paragraph id="H75807950ACD84E8086AC9918F7E381E8"><enum>(2)</enum><text display-inline="yes-display-inline">The level of debt of the covered firm at the end of the applicable year.</text></paragraph><paragraph id="H897C1651AA4F494BBB23892BFAB41AA6"><enum>(3)</enum><text>Information on the debt held by the private equity fund, including—</text><subparagraph id="HF76FA1CFEB6F43FC9A4759EE48EE7E19"><enum>(A)</enum><text>the dollar amount of total debt;</text></subparagraph><subparagraph id="H5AF33E38BF7E4B1498E1BA31178A6CDE"><enum>(B)</enum><text>the percentage of debt for which the creditor is a financial institution in the United States;</text></subparagraph><subparagraph id="HA31025CB3B2541AA91BD213B3BE17B53"><enum>(C)</enum><text>the percentage of debt for which the creditor is a financial institution outside of the United States;</text></subparagraph><subparagraph id="H2B50E2D430124C2B88D6566D24072FF7"><enum>(D)</enum><text>the percentage of debt for which the creditor is an entity that is located in the United States and is not a financial institution; and</text></subparagraph><subparagraph id="H73903CF29D5E41BEBF277CFFC70DDE29"><enum>(E)</enum><text>the percentage of debt for which the creditor is an entity that is located outside of the United States and is not a financial institution.</text></subparagraph></paragraph><paragraph id="HC5FBC17C76E64E71AAC569B441F0889E"><enum>(4)</enum><text display-inline="yes-display-inline">The total amount of debt held by the covered firm that is categorized as—</text><subparagraph id="H75107B914273436A9EB8E674585B3DDB"><enum>(A)</enum><text>liabilities;</text></subparagraph><subparagraph id="HD98E2B1D76604606B2EECC11A51B5B15"><enum>(B)</enum><text>long-term liabilities; and</text></subparagraph><subparagraph id="HBDC232AB8282456295E64EB44F34D26C"><enum>(C)</enum><text>payment in kind or zero coupon debt.</text></subparagraph></paragraph><paragraph id="H5E21FED5CD3B4F51BEA8101443747144"><enum>(5)</enum><text display-inline="yes-display-inline">The average debt-to-equity ratio of—</text><subparagraph id="HD480396545134F80A23DB0AE0AE95A48"><enum>(A)</enum><text>each covered firm with respect to the private equity fund; and</text></subparagraph><subparagraph id="HD86F207BBF914DD8AA5F74020295F06E"><enum>(B)</enum><text>the private equity fund.</text></subparagraph></paragraph><paragraph id="H6FDBCC960E6B43CAA56C74F02D4CEB51"><enum>(6)</enum><text display-inline="yes-display-inline">The average debt-to-EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of each covered firm with respect to the private equity fund.</text></paragraph><paragraph id="HE4DE0AC3BA1341EFA7C9334839B415E4"><enum>(7)</enum><text display-inline="yes-display-inline">The total number of covered firms with respect to the private equity fund that experienced a default during the applicable year, and the name of any such covered firm.</text></paragraph><paragraph id="H604ED1EBA3C7474D89338ABD95EDD34C"><enum>(8)</enum><text display-inline="yes-display-inline">The total gross asset value of each covered firm with respect to the private equity fund.</text></paragraph><paragraph id="H59618F729F7A4FFA81AA39BEB5C347DC"><enum>(9)</enum><text display-inline="yes-display-inline">The gross performance of the private equity fund during the applicable year.</text></paragraph><paragraph id="H8A5F0040BF784EBFA0923DD4AA022AD2"><enum>(10)</enum><text display-inline="yes-display-inline">The total dollar amount of aggregate fees and expenses collected by the private equity fund, the manager of the fund, or related parties from covered firms with respect to the private equity fund, which shall—</text><subparagraph id="H8057EBC3E9C24033B3E0F27EA576BD10"><enum>(A)</enum><text>be categorized by the type of fee; and</text></subparagraph><subparagraph id="H564AAE6FFC904AF4920D79B656791366"><enum>(B)</enum><text>include a description of the purpose of the fees.</text></subparagraph></paragraph><paragraph id="HFFBF02B452894E0C9E155BC0EBE8302A"><enum>(11)</enum><text display-inline="yes-display-inline">Any transaction, monitoring, management, performance, or other fees collected by the private equity fund from the covered firm.</text></paragraph><paragraph id="H91D3E9C56F2948B9A1E8BB1CD7AB5564"><enum>(12)</enum><text display-inline="yes-display-inline">In dollars, the total amount of regulatory assets under management by the private equity fund.</text></paragraph><paragraph id="HA24A944B876740FAADBA0470B860BEBB"><enum>(13)</enum><text>In dollars, the total amount of net assets under management by the private equity fund.</text></paragraph><paragraph id="HA28C901F649B46FC8DD88715DA3E5318"><enum>(14)</enum><text>With respect to the applicable year, the difference obtained by subtracting the financial gains of the private equity fund by the fees that the general partners of the fund charged to the limited partners of the fund (commonly referred to as the <quote>performance net of fees</quote>).</text></paragraph><paragraph id="HE0D4D28D58064B16BA5831AB19D3CBD2"><enum>(15)</enum><text display-inline="yes-display-inline">Any management services agreements between the covered firm and the private equity fund, including a disclosure of fees paid through management services agreements.</text></paragraph><paragraph id="HB6FA8DD49B5F447595207FC56E1790A0"><enum>(16)</enum><text>Any other services procured by the covered firm from the private equity fund or any other company owned by the private equity fund.</text></paragraph><paragraph id="HD1D44EE95BD24F6E9B021E391CA9BB01"><enum>(17)</enum><text display-inline="yes-display-inline">Dividends paid by the covered firm to the private equity fund.</text></paragraph><paragraph id="HB2298FFABB044CC49EA898A52F657729"><enum>(18)</enum><text display-inline="yes-display-inline">The names of—</text><subparagraph id="H52BB0F4993EE46BA996EAC88D27DCEC4"><enum>(A)</enum><text>the limited partners of the private equity fund;</text></subparagraph><subparagraph id="H5CBAE0080AAF4733A51F5C01FAA12DC6"><enum>(B)</enum><text>the board members of the private equity fund; and</text></subparagraph><subparagraph id="H26217307ABF047268C3792E8848C6A61"><enum>(C)</enum><text>the leadership of the covered firm.</text></subparagraph></paragraph><paragraph id="H8EF532BA9F58481D80D5E7196D8355E5"><enum>(19)</enum><text display-inline="yes-display-inline">All political spending by the covered firm, including contributions, lobbying spending, and contributions to groups that do not share their donor list.</text></paragraph><paragraph id="H72D43110FBE146A880933BECE387575C"><enum>(20)</enum><text display-inline="yes-display-inline">All political spending by the private equity fund, an affiliate of the fund, or an investment professional at the fund, with respect to—</text><subparagraph id="H9E23477E234B4D04A6DBDB311EC69BDC"><enum>(A)</enum><text>health care related issues; or</text></subparagraph><subparagraph id="H708C0782683F451BBB61E20CD3A8BFAF"><enum>(B)</enum><text>members of congressional committees with oversight of health care.</text></subparagraph></paragraph><paragraph id="H2259BDEC0F97440D9BE9A5AD8AB974A1"><enum>(21)</enum><text display-inline="yes-display-inline">Information on the extent to which the covered firm entered into any sale lease back transactions with the private equity fund.</text></paragraph><paragraph id="H27BE849D48334A9BBA77F416859F6926"><enum>(22)</enum><text>Every asset purchased by the covered firm during the applicable year.</text></paragraph><paragraph id="H7F7BDE6959CE4403A25E087D3A5CB78B"><enum>(23) </enum><text display-inline="yes-display-inline">Information that is similar to the information of the kind that would be required to be included in a notification filed pursuant to the rules issued under subsection 7A(d)(1) of the Clayton Act (<external-xref legal-doc="usc" parsable-cite="usc/15/18a">15 U.S.C. 18a(d)(1)</external-xref>).</text></paragraph><paragraph id="HC51C7AFEA2D641B097CD38767C1DF278" commented="no"><enum>(24)</enum><text display-inline="yes-display-inline">Data related to real estate, mortgage, and lease payments.</text></paragraph><paragraph id="HE5F1104FF10148B08C6DB961B167532E"><enum>(25)</enum><text display-inline="yes-display-inline">Interest expenses and payments made by the private equity fund and each covered firm with respect to the private equity fund to comply with tax receivable agreements.</text></paragraph><paragraph id="HB20AA9704EAE4F1EB8C5D1DA46C4DA68"><enum>(26)</enum><text display-inline="yes-display-inline">Average interest rate paid on secured and unsecured lines of credit by the private equity fund and each covered firm with respect to the private equity fund.</text></paragraph><paragraph id="HC1EC9300CB5B48E496A1EC0481F18AD1"><enum>(27)</enum><text display-inline="yes-display-inline">For the private equity fund and each covered firm with respect to the private equity fund, a list of—</text><subparagraph id="H435A409EDBF6439C8E71719C6593D38B"><enum>(A)</enum><text>all transactions with the 10 largest vendors or service providers; and</text></subparagraph><subparagraph id="H36CE53C46E8146AC8943D4A1072B54E5"><enum>(B)</enum><text>any new vendors or service providers.</text></subparagraph></paragraph><paragraph id="H798BA3519CEB437A8778272A0CBE64B2"><enum>(28)</enum><text display-inline="yes-display-inline">For the private equity fund and each covered firm with respect to the private equity fund, the number of payments to staffing firms.</text></paragraph></subsection><subsection id="H2136C33FBB914134B2C74968EE092CD8"><enum>(c)</enum><header>Information submitted by covered firms not owned by private equity</header><text display-inline="yes-display-inline">For purposes of subsection (a) and with respect to a covered firm, the information described in this subsection is the following information with respect to each year of the previous 10-year period:</text><paragraph id="HA4B534B4E7E44215865C85A0647A1DA8"><enum>(1)</enum><text display-inline="yes-display-inline">The level of debt of the covered firm at the end of the applicable year.</text></paragraph><paragraph id="HBA0937A7BA9D45568DBFF379B2BBA302"><enum>(2)</enum><text display-inline="yes-display-inline">The total amount of debt held by the covered firm that is categorized as—</text><subparagraph id="H0B3AB6B80FDC4707887CAD846EE716E4"><enum>(A)</enum><text>liabilities;</text></subparagraph><subparagraph id="HB88580386BA348BD8C137AACB48B926B"><enum>(B)</enum><text>long-term liabilities; and</text></subparagraph><subparagraph id="H9AA09B4C23994E399FDA9A777F4981AD"><enum>(C)</enum><text>payment in kind or zero coupon debt.</text></subparagraph></paragraph><paragraph id="HF911DC4C28534D249388F00D6023DD6B"><enum>(3)</enum><text display-inline="yes-display-inline">The average debt-to-equity ratio of the covered firm.</text></paragraph><paragraph id="H4C55EDE915774D5B8CA510146E10F858"><enum>(4)</enum><text display-inline="yes-display-inline">The average debt-to-EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of the covered firm.</text></paragraph><paragraph id="H21B7FC57C1304FCB9363225D40AE7EB0"><enum>(5)</enum><text display-inline="yes-display-inline">Whether the covered firm experienced a default during the applicable year.</text></paragraph><paragraph id="H4F13D1C60F9949B58DF88E6515E6F864"><enum>(6)</enum><text display-inline="yes-display-inline">The total gross asset value of the covered firm.</text></paragraph><paragraph id="H1F1CBD92152245C8B9AE48E2465E9E6D"><enum>(7)</enum><text display-inline="yes-display-inline">Dividends paid by the covered firm.</text></paragraph><paragraph id="HF837949E96DB4224B0654178797EF32F"><enum>(8)</enum><text display-inline="yes-display-inline">The names of the leadership of the covered firm.</text></paragraph><paragraph id="H1847E385315D43B9A69BB5FFC2BE1BC7"><enum>(9)</enum><text display-inline="yes-display-inline">All political spending by the covered firm, including contributions, lobbying spending, and contributions to groups that do not share their donor list.</text></paragraph><paragraph id="HBDADBE13DB654B4BAD64082CC21ADFD0"><enum>(10)</enum><text>Every asset purchased by the covered firm during the applicable year.</text></paragraph><paragraph id="H078E023A719740279A34D2882D9E06DD"><enum>(11)</enum><text display-inline="yes-display-inline">Information that is similar to the information of the kind that would be required to be included in a notification filed pursuant to the rules issued under subsection 7A(d)(1) of the Clayton Act (<external-xref legal-doc="usc" parsable-cite="usc/15/18a">15 U.S.C. 18a(d)(1)</external-xref>).</text></paragraph><paragraph id="H71EE99435A9C4DFEB90F0D910C890C6D" commented="no"><enum>(12)</enum><text display-inline="yes-display-inline">Data related to real estate, mortgage, and lease payments.</text></paragraph><paragraph id="HED4E7A06C11A40A89CCF81AABA0F24C7"><enum>(13)</enum><text display-inline="yes-display-inline">Interest expenses and payments made to comply with tax receivable agreements.</text></paragraph><paragraph id="H1985F42691D54A8D86E29AEEA46528A2"><enum>(14)</enum><text display-inline="yes-display-inline">Average interest rate paid on secured and unsecured lines of credit.</text></paragraph><paragraph id="H75E9A143E601442090F96B23AC042CCC"><enum>(15)</enum><text display-inline="yes-display-inline">A list of—</text><subparagraph id="H41707FF160C34508BEBA22D4771CB3A7"><enum>(A)</enum><text>all transactions with the 10 largest vendors or service providers; and</text></subparagraph><subparagraph id="HBE81CFAFBD0E4D6096BA4D8B38B8613D"><enum>(B)</enum><text>any new vendors or servicer providers.</text></subparagraph></paragraph><paragraph id="H2BDBC462F23344859FA2EADAB7722320"><enum>(16)</enum><text display-inline="yes-display-inline">The number of payments to staffing firms.</text></paragraph></subsection><subsection id="HBD2F5EFA9AC446B690AE97C7F8B57817" display-inline="no-display-inline"><enum>(d)</enum><header>Requirement To provide information to a covered firm</header><text>A private equity fund that is a control person of a covered firm shall provide the covered firm with any information required to complete a disclosure under this section.</text></subsection><subsection id="H9F20B6BB6CD54315A7FDCD37BC70E5BA"><enum>(e)</enum><header>GAO analysis</header><paragraph id="HC80330BEF8E44CDD985694071AE208A4"><enum>(1)</enum><header>Analysis</header><text>Not later than 12 months after the date of implementation of this section, and every 3 years thereafter during the 12-year period beginning on the date of the enactment of this section, the Comptroller General of the United States shall conduct a comparative analysis, using the information submitted under this section, to determine to what extent health care consolidation is taking place and how this consolidation and private equity’s involvement in health care is contributing, among other factors, to the following indicators:</text><subparagraph id="HE2EFB1C14AD043A0BAA4C299EEE5617E"><enum>(A)</enum><text display-inline="yes-display-inline">Revenue and cost to charge ratio.</text></subparagraph><subparagraph id="H59F9835D2DBE4CC2BB662B5F8D34F9EA"><enum>(B)</enum><text display-inline="yes-display-inline">Payor mix and case mix index.</text></subparagraph><subparagraph id="H0A3AA6010C614F5F83E8A3A137BB63B2"><enum>(C)</enum><text>In-network versus out of network referrals.</text></subparagraph><subparagraph id="H0182E3B867CF48FB9B1996A0A61B0F0D"><enum>(D)</enum><text>Quality ratings for the health care facilities.</text></subparagraph><subparagraph id="HFC32389C6EC24F5F8A90DA89E929E2BA"><enum>(E)</enum><text display-inline="yes-display-inline">Regulation compliance violations, including dischargers for patients with Medicare or Medicaid coverage and total discharges per year.</text></subparagraph><subparagraph id="H43EEE8B3AE8143D1B42EFBBC5393D524"><enum>(F)</enum><text>Staffing levels and ratios.</text></subparagraph><subparagraph id="HD758B846F20745DDB2D210A72E3E8573"><enum>(G)</enum><text>Employee wages.</text></subparagraph><subparagraph id="H81D058749EB5424EAC5EB4B0DB7516C6"><enum>(H)</enum><text>Hospital capacity, including number of beds.</text></subparagraph></paragraph><paragraph id="H72388979FEE44735B95592831AD496F2"><enum>(2)</enum><header>Report</header><text display-inline="yes-display-inline">After each analysis required under paragraph (1) is completed, the Comptroller General shall issue a report on all findings and conclusions made in carrying out such analysis to the Congress, the Secretary of Health and Human Services, and the task force established under section 3 of the Healthcare Ownership Transparency Act.</text></paragraph></subsection><subsection id="HEF9FB90A9CFE4F7C9D9099856C63613F"><enum>(f)</enum><header>Audits</header><text display-inline="yes-display-inline">The Secretary shall audit a random sample annually of applications submitted through the Provider Enrollment, Chain, and Ownership System as part of the enrollment and revalidation of enrollment processes under title XVIII to verify compliance with the requirements of this section and accuracy of information submitted pursuant to this section. </text></subsection><subsection id="H0CD64188F7374A37BEA712BC00AF3A32"><enum>(g)</enum><header>Definitions</header><text>In this section:</text><paragraph id="HA37678B463EE4751ABBCB5A7DD3FBD1F"><enum>(1)</enum><header>Affiliate</header><text>The term <term>affiliate</term> means—</text><subparagraph id="H97A36F8EAC2F49F6B8996F77079EC874"><enum>(A)</enum><text>a person that directly or indirectly owns, controls, or holds with power to vote, 20 percent or more of the outstanding voting securities of another entity, other than a person that holds such securities—</text><clause id="HD2C59E44778745438AB509E0643B1E91"><enum>(i)</enum><text>in a fiduciary or agency capacity without sole discretionary power to vote such securities; or</text></clause><clause id="H5044B46E41154705892073121CEA611F"><enum>(ii)</enum><text>solely to secure a debt, if such entity has not in fact exercised such power to vote;</text></clause></subparagraph><subparagraph id="H28076AAD289046C6A4783D6A1CDC0DDE"><enum>(B)</enum><text>a corporation 20 percent or more of whose outstanding voting securities are directly or indirectly owned, controlled, or held with power to vote, by another entity (referred to in this subparagraph as a <quote>covered entity</quote>), or by an entity that directly or indirectly owns, controls, or holds with power to vote, 20 percent or more of the outstanding voting securities of the covered entity, other than an entity that holds such securities—</text><clause id="H7C6053060270476EBC7B66FB871D7417"><enum>(i)</enum><text>in a fiduciary or agency capacity without sole discretionary power to vote such securities; or</text></clause><clause id="H837E94CABD0D4B158D824700E12C6F17"><enum>(ii)</enum><text>solely to secure a debt, if such entity has not in fact exercised such power to vote;</text></clause></subparagraph><subparagraph id="H3C578999F3A9443BB7B864F55B3FAA7B"><enum>(C)</enum><text>a person whose business is operated under a lease or operating agreement by another entity, or person substantially all of whose property is operated under an operating agreement with that other entity; or</text></subparagraph><subparagraph id="H2F2C8D49F7524ACEB064707088181611"><enum>(D)</enum><text>an entity that operates the business or substantially all of the property of another entity under a lease or operating agreement.</text></subparagraph></paragraph><paragraph id="H513241ED51F648A2BB2E83E890E315AD"><enum>(2)</enum><header>Control person</header><text>The term <term>control person</term>—</text><subparagraph id="H52E4733FCE284749954DFD4DE60A7316"><enum>(A)</enum><text>means a person that directly or indirectly owns, controls, or holds—</text><clause id="HC742A52D8A374A20A35590C3A05514F8"><enum>(i)</enum><text display-inline="yes-display-inline"> the power to vote more than 20 percent of any class of voting securities of a covered firm; or</text></clause><clause id="H5468B52B1B4E4904887DB7A385FD59EF"><enum>(ii)</enum><text display-inline="yes-display-inline">any lesser percentage of any class of voting securities of a covered firm that is sufficient to give the ability to direct the actions of the covered firm; and</text></clause></subparagraph><subparagraph id="H51044684B0F34608A9831D1A954A463E"><enum>(B)</enum><text>does not include a person that—</text><clause id="H75E4641EDBF747C0B0B25C0EBC5E73D7"><enum>(i)</enum><text>holds the voting interests of a covered firm solely—</text><subclause id="H04060E66B71E4C91AAC523CB8E4E90A3"><enum>(I)</enum><text>in a fiduciary or agency capacity without sole discretionary power to vote the securities; or</text></subclause><subclause id="H6722A80961F346D59E4FAC283D286B28"><enum>(II)</enum><text>to secure a debt, if the person has not exercised the power to vote; or</text></subclause></clause><clause id="H2B1EB446D06347329F837969F6185802"><enum>(ii)</enum><subclause commented="no" display-inline="yes-display-inline" id="HCA5CF32F3F6947FBA3A2EFB84BC29630"><enum>(I)</enum><text>is a limited partner with respect to a person described in subparagraph (A) that is a partnership; and</text></subclause><subclause id="H5EE327F869AB4679AA4B548340ADA08B" indent="up1"><enum>(II)</enum><text>does not participate in the direction of the management or policy of the covered firm.</text></subclause></clause></subparagraph></paragraph><paragraph id="H5983075F4291437D8FB07ED573829A8C"><enum>(3)</enum><header>Corporation</header><text>The term <term>corporation</term> means—</text><subparagraph id="H6B828FEFBA7E4ABFA6D3C7D3D548A4D8"><enum>(A)</enum><text>a joint-stock company;</text></subparagraph><subparagraph id="HACC1D713B6B74C60B35EDEBD72A0BA36"><enum>(B)</enum><text>a company or partnership association organized under a law that makes only the capital subscribed or callable up to a specified amount responsible for the debts of the association, including a limited partnership and a limited liability company;</text></subparagraph><subparagraph id="H2CBEA21D920F4626B517A8255442914B"><enum>(C)</enum><text>a trust; and</text></subparagraph><subparagraph id="H267D7F39B3A64A6F8230F0D3A5571930"><enum>(D)</enum><text>an association having a power or privilege that a private corporation, but not an individual or a partnership, possesses.</text></subparagraph></paragraph><paragraph id="HB4E7FE5B96E24AE2A620F1AC52A59836"><enum>(4)</enum><header>Covered firm</header><text>The term <term>covered firm</term> means a corporation that is—</text><subparagraph id="H8AA13E9F18314489A753DC65D6B4A8B3" display-inline="no-display-inline"><enum>(A)</enum><text>a provider of services or supplier that meets all applicable requirements under title XVIII for participating in the Medicare program under such title; or</text></subparagraph><subparagraph id="H63AB3DEFC422480B9BF6A412B13A70E9"><enum>(B)</enum><text>any other person or entity who may receive reimbursements, payments, or other funds from the Centers for Medicare &amp; Medicaid Services.</text></subparagraph></paragraph><paragraph id="H745535B1F5F34639BADDAC1E3349FAA7"><enum>(5)</enum><header>Private equity fund</header><text display-inline="yes-display-inline">The term <term>private equity fund</term> means—</text><subparagraph id="HDD1E6A48AA134BB4A4C0AA969AA73758"><enum>(A)</enum><clause commented="no" display-inline="yes-display-inline" id="H6A1B364F4E584929BF220876AA648182"><enum>(i)</enum><text display-inline="yes-display-inline">a company or partnership that would be considered an investment company under section 3 of the Investment Company Act of 1940 (<external-xref legal-doc="usc" parsable-cite="usc/15/80a-3">15 U.S.C. 80a–3</external-xref>) but for the application of paragraph (1) or (7) of subsection (c) of such section 3;</text></clause><clause id="H709F1F374805438A8F278C3CA173C843" indent="up1"><enum>(ii)</enum><text display-inline="yes-display-inline">a venture capital fund, as defined under section 275.203(l)–1of title 17, Code of Federal Regulations; or</text></clause><clause id="H716653D73B08421990D28A110F16888A" indent="up1"><enum>(iii)</enum><text>a sovereign wealth fund; and</text></clause></subparagraph><subparagraph id="HCFE3DD995FD948E1A25C40A2AE3D98B4"><enum>(B)</enum><text>directly, or through an affiliate, acts as a control person.</text></subparagraph></paragraph></subsection></section><after-quoted-block>.</after-quoted-block></quoted-block></subsection><subsection id="H9B10F047C68B4352BE48622A56583315"><enum>(b)</enum><header>Exclusion from participation under Medicare</header><text>Section 1128(b) of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1320a-7">42 U.S.C. 1320a–7(b)</external-xref>) is amended by adding at the end the following new paragraph:</text><quoted-block style="OLC" id="H7CDEA885B03542A6973FF9243637476C" display-inline="no-display-inline"><paragraph id="H37470766C8A94BF7B1654D1E84A5123E"><enum>(18)</enum><header>Failure to disclose certain PECOS information</header><text display-inline="yes-display-inline">With respect to exclusion pursuant to this subsection from participation in the Medicare program under title XVIII, any entity to which section 1150C applies that did not fully and accurately make any disclosure required by such section.</text></paragraph><after-quoted-block>.</after-quoted-block></quoted-block></subsection></section><section id="HA412170A718848778BEC23A2C9D57488" section-type="subsequent-section"><enum>3.</enum><header>Task Force to Analyze and Provide Recommendations on the Role of Private Equity and Consolidation in Health Care</header><subsection id="H8DF5B5CF257742B9921D8094887F93E7"><enum>(a)</enum><header>Establishment</header><text display-inline="yes-display-inline">The Secretary of Health and Human Services shall establish and operate a task force to address and limit the role of private equity and consolidation in healthcare (the <quote>Task Force</quote>).</text></subsection><subsection id="HEDAFA2449D1E47B69725E0E2A6995BE9"><enum>(b)</enum><header>Composition</header><paragraph id="HC1BAF2CE9CEC4C22A5388A0E6B473536"><enum>(1)</enum><header>Chair</header><text>The Secretary of Health and Human Services shall chair the Task Force.</text></paragraph><paragraph id="H20709B0770134630B415C0F701E99252"><enum>(2)</enum><header>Members</header><text>The Secretary shall appoint the members of the Task Force from among the following:</text><subparagraph id="HE8A05DF4022E4DA09E8BC56674B221C4"><enum>(A)</enum><text>Academic experts and researchers with expertise on—</text><clause id="H6C068520E97C44E396CCDCACA4709C0B"><enum>(i)</enum><text>the role of private equity in healthcare; and</text></clause><clause id="HF3A3A398E544474DBEB2401AFA1944EA"><enum>(ii)</enum><text>the impact of mergers and acquisitions in healthcare on costs and patients.</text></clause></subparagraph><subparagraph id="H08FD645D6DC443FDB0C4D098844291AB"><enum>(B)</enum><text>Representatives from organizations focused on consumer protection, antitrust, patient advocacy, and worker advocacy.</text></subparagraph><subparagraph id="H827B2D47CB314BD1AD33E077169158EA"><enum>(C)</enum><text>Hospital and health care staff.</text></subparagraph><subparagraph id="HDD12FA4FBCA34A6FA8342349F4094E28"><enum>(D)</enum><text>Patients.</text></subparagraph></paragraph><paragraph id="H27E90D615B9A43E692A1AF16CCBC4577"><enum>(3)</enum><header>Advisory members</header><text>In addition to the members described under paragraph (2), the chairman of the Federal Trade Commission and the Attorney General shall serve as advisory members of the Task Force.</text></paragraph><paragraph id="HDA5D893E94BA4E0FBBA115BF1D8FBA72"><enum>(4)</enum><header>Member appointment</header><text>Not later than 60 days after the receipt of the first report issued by the Comptroller General of the United States under section 1150C of the Social Security Act, the Secretary of Health and Human Services shall appoint the members of the Task Force—</text><subparagraph id="HD0FEEF9104EA4250A6633C6D56E34740"><enum>(A)</enum><text>in accordance with paragraph (2); and</text></subparagraph><subparagraph id="H9BB6C36D3AD74CA893E1FEC1202F19F5"><enum>(B)</enum><text>using a competitive application process.</text></subparagraph></paragraph></subsection><subsection id="H638A1E7231154E2CABEB85CB70055F62"><enum>(c)</enum><header>Recommendations</header><text display-inline="yes-display-inline">The Task Force shall, based on the results of such study and the report issued by the Comptroller General of the United States under section 1150C of the Social Security Act identify best practices (and for purposes of subsection (d) develop recommendations) for limiting the role of private equity in health care, taking into account the implications on health outcomes and staff working conditions.</text></subsection><subsection id="H4723C29AE90548F5AFEE7EB2B0653A67"><enum>(d)</enum><header>Report</header><text>Not later than 6 months after the date of the first report issued by the Comptroller General of the United States under section 1150C of the Social Security Act, and every 6 months thereafter, the Secretary of Health and Human Services shall submit to Congress a report—</text><paragraph id="H4F8BB87563A84004B59AB18FE38FD782"><enum>(1)</enum><text>on the recommendations developed subsection (c); and</text></paragraph><paragraph id="HFF43ED31B9A14182BF8FBACAA491DFC6"><enum>(2)</enum><text display-inline="yes-display-inline">that includes regulatory and legislative recommendations to address any adverse effects of health care consolidation and private equity’s involvement in health care.</text></paragraph></subsection><subsection id="HA0470BB214A9426E8799D3FAA23384B8"><enum>(e)</enum><header>Moratorium</header><paragraph id="H086D8356AB4A49DBA976BCED54BF2803"><enum>(1)</enum><header>In general</header><text>The Secretary of Health and Human Services may prohibit a private equity fund from purchasing voting securities of a covered firm, and may prohibit any merger or acquisition that would result in a private equity fund gaining control of voting securities of a covered firm, until the date on which the Secretary determines that the Task Force has had sufficient time to study and identify whether abuses are taking place in specific health care sectors or by health care entities related to price gauging, understaffing, regulation compliance violations, or such other metrics as the Secretary may determinate appropriate.</text></paragraph><paragraph id="H4424A31FB6AC43FFAC9BA00AD227979C"><enum>(2)</enum><header>Definitions</header><text>In this subsection:</text><subparagraph id="HF1D3FE64A6BE41C9AFE39AC471F0FC58"><enum>(A)</enum><header>Covered firm</header><text>The term <term>covered firm</term> has the meaning given that term under section 1150C(g) of the Social Security Act.</text></subparagraph><subparagraph id="H92BCCCAABBA54F608CAD802D02C7C6A9"><enum>(B)</enum><header>Private equity fund</header><text>The term <term>private equity fund</term> means—</text><clause id="H30A638529B064FDD862F09327FB57843"><enum>(i)</enum><text>a company or partnership that would be considered an investment company under section 3 of the Investment Company Act of 1940 (<external-xref legal-doc="usc" parsable-cite="usc/15/80a-3">15 U.S.C. 80a–3</external-xref>) but for the application of paragraph (1) or (7) of subsection (c) of such section 3;</text></clause><clause id="H555AAD433F3E4DA3B807C71C711CFA80"><enum>(ii)</enum><text display-inline="yes-display-inline">a venture capital fund, as defined under section 275.203(l)–1of title 17, Code of Federal Regulations; and</text></clause><clause id="HBD4AC58D84AA498EB2EB781F90A4105E"><enum>(iii)</enum><text>a sovereign wealth fund.</text></clause></subparagraph></paragraph></subsection></section></legis-body></bill> 

